GIP infusion decreased resistin levels, an adipokine involved in inflammation and atherosclerosis in a similar way to sitagliptin, suggesting that DPP-4 inhibition produced by sitagliptin provides beneficial effects through the mediation of GIP. The gene discussed is GIP; the disease is atherosclerosis.